Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
- 28 November 2016
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 45 (2), 216-223
- https://doi.org/10.1124/dmd.116.072652
Abstract
The age-dependent absolute protein abundance of carboxylesterase (CES) 1 and CES2 in human liver was investigated and applied to predict infant pharmacokinetics (PK) of oseltamivir. The CES absolute protein abundance was determined by liquid chromatography-tandem mass spectrometry proteomics in human liver microsomal and cytosolic fractions prepared from tissue samples obtained from 136 pediatric donors and 35 adult donors. Two surrogate peptides per protein were selected for the quantification of CES1 and CES2 protein abundance. Purified CES1 and CES2 protein standards were used as calibrators, and the heavy labeled peptides were used as the internal standards. In hepatic microsomes, CES1 and CES2 abundance (in picomoles per milligram total protein) increased approximately 5-fold (315.2 vs. 1664.4) and approximately 3-fold (59.8 vs. 174.1) from neonates to adults, respectively. CES1 protein abundance in liver cytosol also showed age-dependent maturation. Oseltamivir carboxylase activity was correlated with protein abundance in pediatric and adult liver microsomes. The protein abundance data were then used to model in vivo PK of oseltamivir in infants using pediatric physiologically based PK modeling and incorporating the protein abundance–based ontogeny function into the existing pediatric Simcyp model. The predicted pediatric area under the curve, maximal plasma concentration, and time for maximal plasma concentration values were below 2.1-fold of the clinically observed values, respectively.Keywords
This publication has 40 references indexed in Scilit:
- Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal OntogenyDrug Metabolism and Disposition, 2016
- Hepatic, Intestinal, Renal, and Plasma Hydrolysis of Prodrugs in Human, Cynomolgus Monkey, Dog, and Rat: Implications for In Vitro–In Vivo Extrapolation of Clearance of ProdrugsDrug Metabolism and Disposition, 2014
- The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effectDrug Metabolism and Drug Interactions, 2014
- Drug Labeling and Exposure in NeonatesJAMA Pediatrics, 2014
- Application of Physiologically Based Pharmacokinetic Modeling to Predict Acetaminophen Metabolism and Pharmacokinetics in ChildrenCPT: Pharmacometrics & Systems Pharmacology, 2013
- Western Blots versus Selected Reaction Monitoring Assays: Time to Turn the Tables?Molecular & Cellular Proteomics, 2013
- Developmental expression of drug metabolizing enzymes: Impact on disposition in neonates and young childrenInternational Journal of Pharmaceutics, 2012
- Paediatric drug use with focus on off‐label prescriptions at Swedish hospitals – a nationwide studyActa Paediatrica, 2012
- Antiplatelet Agents Aspirin and Clopidogrel Are Hydrolyzed by Distinct Carboxylesterases, and Clopidogrel Is Transesterificated in the Presence of Ethyl AlcoholJournal of Pharmacology and Experimental Therapeutics, 2006
- The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes Differential hydrolysis for the lactone and carboxylate formsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1997